NYSE (USD): Haemonetics Corporation (HAE)
Last Price
77.72
Today's Change
-1.09 (1.38%)
Day's Change
77.31 - 80.01
Trading Volume
358,351
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Regulator Sues Buffett's Berkshire Unit Over Risky Home Loans
2
US 30-year Bond Yield Highest Since 2023
3
GoTo Gives CEO Five Years More to Get Car-hailing Firm to Profit
4
Trump Says His Tariff Policy Won’t be Pared Back
5
Biden Bars Offshore Oil Drilling in US Atlantic and Pacific
#
Stock
Score
LAES
SEALSQ Corp
AGN
BABA
Alibaba Group Holding Limited
NVDA
NVIDIA Corporation
750
QBTS
D-Wave Quantum Inc.
6
PLTR
Palantir Technologies Inc.
7
OPNT
Opiant Pharmaceuticals, Inc.
550
8
NKE
NIKE, Inc.
500
9
GETY
Getty Images Holdings, Inc.
10
EGL
Engility Holdings, Inc.
Last
Change
Volume
XTIA
0.114
+0.026
2,420,455,277
SVMH
0.084
+0.038
1,314,960,896
CERO
0.052
+0.01
890,136,351
RIME
0.227
+0.082
667,058,209
HOTH
2.28
+1.46
414,652,810
SLNA
0.03
-0.008
379,091,456
FUBO
5.46
+0.40
376,563,353
CYXT
0.065
0.00
369,807,727
140.14
-9.29
342,943,877
UWT
0.164
-0.002
244,137,454
BRK-A
678,560.00
+1,956.00
1,168
RTLA
209.90
+74.87
0
DFGP
52.53
+52.53
53,947
DGCB
52.23
+52.23
22,573
DFGX
52.11
+52.11
31,436
PABD
51.70
+51.70
QQA
50.50
+50.50
5,558
EVSD
50.40
+50.40
26,654
USSH
50.20
+50.20
1,601
USIN
48.41
+48.41
24
MELI
1,774.05
-343.25
2,940,447
MSTR
1,309.00
-138.99
2,237,917
BKNG
4,796.10
-113.69
208,271
MKL
1,395.13
-102.30
318,280
LOWC
30.18
-92.412
1,236,074
NVR
7,897.00
-91.67
26,850
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
BH-A
1,170.00
-83.95
1,323
MEDP
357.30
-79.88
1,004,401
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....